Report Detail

Pharma & Healthcare Global (United States, European Union and China) Chronic Kidney Disease (CKD) Drugs Market Research Report 2019-2025

  • RnM3669872
  • |
  • 14 August, 2019
  • |
  • Global
  • |
  • 117 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global (United States, European Union and China) Chronic Kidney Disease (CKD) Drugs Market Research Report 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 ACE inhibitors
      • 1.3.3 Angiotensin-II receptor blockers
      • 1.3.4 Calcium channel blockers
      • 1.3.5 Beta blockers: BREVIBLOC, Bystolic
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Chronic Kidney Disease (CKD) Drugs Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Specialty Clinics
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Chronic Kidney Disease (CKD) Drugs Market Size
      • 2.1.1 Global Chronic Kidney Disease (CKD) Drugs Revenue 2014-2025
      • 2.1.2 Global Chronic Kidney Disease (CKD) Drugs Sales 2014-2025
    • 2.2 Chronic Kidney Disease (CKD) Drugs Growth Rate by Regions
      • 2.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers
      • 3.1.1 Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Chronic Kidney Disease (CKD) Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Chronic Kidney Disease (CKD) Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Chronic Kidney Disease (CKD) Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Chronic Kidney Disease (CKD) Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Chronic Kidney Disease (CKD) Drugs Market
    • 3.6 Key Manufacturers Chronic Kidney Disease (CKD) Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 ACE inhibitors Sales and Revenue (2014-2019)
      • 4.1.2 Angiotensin-II receptor blockers Sales and Revenue (2014-2019)
      • 4.1.3 Calcium channel blockers Sales and Revenue (2014-2019)
      • 4.1.4 Beta blockers: BREVIBLOC, Bystolic Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type
    • 4.3 Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type
    • 4.4 Chronic Kidney Disease (CKD) Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Chronic Kidney Disease (CKD) Drugs Sales by Application

    6 United States

    • 6.1 United States Chronic Kidney Disease (CKD) Drugs Breakdown Data by Company
    • 6.2 United States Chronic Kidney Disease (CKD) Drugs Breakdown Data by Type
    • 6.3 United States Chronic Kidney Disease (CKD) Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Chronic Kidney Disease (CKD) Drugs Breakdown Data by Company
    • 7.2 European Union Chronic Kidney Disease (CKD) Drugs Breakdown Data by Type
    • 7.3 European Union Chronic Kidney Disease (CKD) Drugs Breakdown Data by Application

    8 China

    • 8.1 China Chronic Kidney Disease (CKD) Drugs Breakdown Data by Company
    • 8.2 China Chronic Kidney Disease (CKD) Drugs Breakdown Data by Type
    • 8.3 China Chronic Kidney Disease (CKD) Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Chronic Kidney Disease (CKD) Drugs Breakdown Data by Company
    • 9.2 Rest of World Chronic Kidney Disease (CKD) Drugs Breakdown Data by Type
    • 9.3 Rest of World Chronic Kidney Disease (CKD) Drugs Breakdown Data by Application
    • 9.4 Rest of World Chronic Kidney Disease (CKD) Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Chronic Kidney Disease (CKD) Drugs Sales by Countries
      • 9.4.2 Rest of World Chronic Kidney Disease (CKD) Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer, Inc.
      • 10.1.1 Pfizer, Inc. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Chronic Kidney Disease (CKD) Drugs
      • 10.1.4 Chronic Kidney Disease (CKD) Drugs Product Introduction
      • 10.1.5 Pfizer, Inc. Recent Development
    • 10.2 Amgen
      • 10.2.1 Amgen Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Chronic Kidney Disease (CKD) Drugs
      • 10.2.4 Chronic Kidney Disease (CKD) Drugs Product Introduction
      • 10.2.5 Amgen Recent Development
    • 10.3 Roche
      • 10.3.1 Roche Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Chronic Kidney Disease (CKD) Drugs
      • 10.3.4 Chronic Kidney Disease (CKD) Drugs Product Introduction
      • 10.3.5 Roche Recent Development
    • 10.4 GlaxoSmithKline (GSK)
      • 10.4.1 GlaxoSmithKline (GSK) Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Chronic Kidney Disease (CKD) Drugs
      • 10.4.4 Chronic Kidney Disease (CKD) Drugs Product Introduction
      • 10.4.5 GlaxoSmithKline (GSK) Recent Development
    • 10.5 Allergan
      • 10.5.1 Allergan Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Chronic Kidney Disease (CKD) Drugs
      • 10.5.4 Chronic Kidney Disease (CKD) Drugs Product Introduction
      • 10.5.5 Allergan Recent Development
    • 10.6 AbbVie
      • 10.6.1 AbbVie Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Chronic Kidney Disease (CKD) Drugs
      • 10.6.4 Chronic Kidney Disease (CKD) Drugs Product Introduction
      • 10.6.5 AbbVie Recent Development
    • 10.7 Kissei Pharmaceutical Co., Ltd.
      • 10.7.1 Kissei Pharmaceutical Co., Ltd. Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Chronic Kidney Disease (CKD) Drugs
      • 10.7.4 Chronic Kidney Disease (CKD) Drugs Product Introduction
      • 10.7.5 Kissei Pharmaceutical Co., Ltd. Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Chronic Kidney Disease (CKD) Drugs Sales Channels
      • 11.2.2 Chronic Kidney Disease (CKD) Drugs Distributors
    • 11.3 Chronic Kidney Disease (CKD) Drugs Customers

    12 Market Forecast

    • 12.1 Global Chronic Kidney Disease (CKD) Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Type
    • 12.3 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Application
    • 12.4 Chronic Kidney Disease (CKD) Drugs Forecast by Regions
      • 12.4.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function.
      Calcium channel blockers surfaced as the key drug class
      The hospitals segment, which is the current market leader, is expected to continue its dominance in this market over the next few years.
      In 2019, the market size of Chronic Kidney Disease (CKD) Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Chronic Kidney Disease (CKD) Drugs.

      This report studies the global market size of Chronic Kidney Disease (CKD) Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Chronic Kidney Disease (CKD) Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer, Inc.
      Amgen
      Roche
      GlaxoSmithKline (GSK)
      Allergan
      AbbVie
      Kissei Pharmaceutical Co., Ltd.
      ...

      Market Segment by Product Type
      ACE inhibitors
      Angiotensin-II receptor blockers
      Calcium channel blockers
      Beta blockers: BREVIBLOC, Bystolic
      Others

      Market Segment by Application
      Hospitals
      Specialty Clinics

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Chronic Kidney Disease (CKD) Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Chronic Kidney Disease (CKD) Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Chronic Kidney Disease (CKD) Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025


      Summary:
      Get latest Market Research Reports on Chronic Kidney Disease (CKD) Drugs. Industry analysis & Market Report on Chronic Kidney Disease (CKD) Drugs is a syndicated market report, published as Global (United States, European Union and China) Chronic Kidney Disease (CKD) Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Chronic Kidney Disease (CKD) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,693.54
      4,040.30
      5,387.07
      2,957.78
      4,436.66
      5,915.55
      349,306.88
      523,960.32
      698,613.76
      235,310.15
      352,965.23
      470,620.30
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report